Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Psychiatric and Cognitive Phenotypes in VCFS, WS and Fragile X Syndrome
NCT00768820Phase 4Recruiting
- Sponsor
- Sheba Medical Center
- Start
- May 2001
- Primary completion
- Aug 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of methylphenidate, fluoxetine, risperidone in Velocardiofacial syndrome (VCFS), Williams syndrome, Fragile X syndrome (FXS), sponsored by Sheba Medical Center. Started May 2001; status: recruiting.
02
Drugs
methylphenidatefluoxetinerisperidone
03
Conditions
Velocardiofacial syndrome (VCFS)Williams syndromeFragile X syndrome (FXS)
Beyond the preview
Go deeper on NCT00768820.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00768820.